about
Fullerenols in therapy and diagnosis of cancerFullerenols as a new therapeutic approach in nanomedicine.Membrane fluidity and activity of membrane ATPases in human erythrocytes under the influence of polyhydroxylated fullerene.Damage to human erythrocytes by radiation-generated HO* radicals: molecular changes in erythrocyte membranes.Phenoxyherbicides induce production of free radicals in human erythrocytes: oxidation of dichlorodihydrofluorescine and dihydrorhodamine 123 by 2,4-D-Na and MCPA-Na.The role of resveratrol and melatonin in the nitric oxide and its oxidation products mediated functional and structural modifications of two glycolytic enzymes: GAPDH and LDH.Fullerenol C₆₀(OH)₃₆ could associate to band 3 protein of human erythrocyte membranes.Can melatonin delay oxidative damage of human erythrocytes during prolonged incubation?Fullerenol C 60 (OH) 36 at relatively high concentrations impairs hippocampal theta oscillations (in vivo and in vitro) and triggers epilepsy (in vitro) – A dose response studyFullerenol C 60 (OH) 36 protects human erythrocyte membrane against high-energy electrons[Fullerenes in radiobiology]Comparison of the effect of phenol and its derivatives on protein and free radical formation in human erythrocytes (in vitro)[Fullerenes in biology]Changes in the activity of acetylcholinesterase and Na,K-ATPase in human erythrocytes irradiated with X-raysThe effect of hypochlorite on human erythrocytes pretreated with X-radiationA Multiparametric Study of Internalization of Fullerenol C60(OH)36 Nanoparticles into Peripheral Blood Mononuclear Cells: Cytotoxicity in Oxidative Stress Induced by Ionizing RadiationChanges in the activities of antioxidant enzymes and reduced glutathione level in human erythrocytes exposed to selected brominated flame retardantsEvaluation of the Effect of Selected Brominated Flame Retardants on Human Serum Albumin and Human Erythrocyte Membrane Proteins
P50
Q28076910-A30938D6-4317-439A-BE9B-B91B32ED2584Q37270329-6F78E13D-0458-4704-AB50-E461A6782CAFQ44428540-21511B3C-5E9D-4901-B506-9D26DEA1FA89Q44712058-A4ADD6DB-85CE-427A-8F85-0D22AEE6D95EQ46986469-6B13D86C-3D2E-43B5-9046-A179EF8714BBQ47242516-072D8351-454E-48D8-8F8B-CBCFEC4BA09FQ50490689-25342B18-038C-42DA-A79E-AC1844269D8CQ51021866-5AD96AB7-6B63-4215-89A9-EF402CDB64ABQ62268619-C405DA54-C53E-41EB-9467-8BAA212E01ABQ62268622-C4E52E95-C7FD-4B0F-9FDE-0780EBC47EAAQ62268657-7C912007-2B03-43CF-A3B8-420EEE1DAEF7Q62268661-44EB64CE-A246-46AC-8C5E-5D79F3C1F65DQ62268662-85BFF96C-01B5-41B0-8D8F-B70F448347B1Q62268667-7A22ADAE-5850-4B8F-8C43-5923A01D95D7Q62268668-51C2568C-94B2-4258-A35C-E13BCC01F615Q90735890-37A2F419-9125-4B6D-B255-67A81A6BC75CQ93101008-D54FBC51-EF18-4ACD-9623-67BD5B5C17DDQ96116849-07142D47-CB49-4447-9945-5682322D57C9
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Anita Krokosz
@ast
Anita Krokosz
@en
Anita Krokosz
@es
Anita Krokosz
@nl
Anita Krokosz
@sl
type
label
Anita Krokosz
@ast
Anita Krokosz
@en
Anita Krokosz
@es
Anita Krokosz
@nl
Anita Krokosz
@sl
altLabel
Anita Marlena Krokosz
@pl
prefLabel
Anita Krokosz
@ast
Anita Krokosz
@en
Anita Krokosz
@es
Anita Krokosz
@nl
Anita Krokosz
@sl
P214
P1053
C-4356-2013
P106
P1153
6602936893
P2038
Anita_Krokosz
P21
P214
P31
P3124
P3829
P496
0000-0002-1008-0548
P735
P7859
viaf-311835158